Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle C Stamper

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|January 24, 2019
Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of <i>Staphylococcus aureus</i> in a Simulated Pharmacodynamic/Pharmacokinetic ModelRazieh Kebriaei, Seth A Rice, Kyle C Stamper, et al.
Infectious Diseases and Therapy|October 5, 2023
Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of DaptomycinRazieh Kebriaei, Jacinda C Abdul-Mutakabbir, Kyle C Stamper, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic ModelRazieh Kebriaei, Katherine L Lev, Kyle C Stamper, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosaSandra Mikhail, Nivedita B Singh, Razieh Kebriaei, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2020
Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insightsRazieh Kebriaei, Seth A Rice, Nivedita B Singh, et al.
Antibiotics (Basel, Switzerland)|October 17, 2020
Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic ModelJacinda C Abdul-Mutakabbir, Razieh Kebriaei, Kyle C Stamper, et al.
Materials (Basel, Switzerland)|July 25, 2018
Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSAKetki Bhise, Samaresh Sau, Razieh Kebriaei, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2021
Exebacase in Addition to Daptomycin against MRSARazieh Kebriaei, Kyle C Stamper, Katherine L Lev, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2020
Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureusRazieh Kebriaei, Katherine Lev, Taylor Morrisette, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2021
<i>In Vitro</i> Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumanniiJacinda C Abdul-Mutakabbir, Logan Nguyen, Philip T Maassen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|January 24, 2019
Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of <i>Staphylococcus aureus</i> in a Simulated Pharmacodynamic/Pharmacokinetic ModelRazieh Kebriaei, Seth A Rice, Kyle C Stamper, et al.
Infectious Diseases and Therapy|October 5, 2023
Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of DaptomycinRazieh Kebriaei, Jacinda C Abdul-Mutakabbir, Kyle C Stamper, et al.
Antimicrobial Agents and Chemotherapy|October 20, 2020
Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an <i>In Vitro</i> Pharmacokinetic/Pharmacodynamic ModelRazieh Kebriaei, Katherine L Lev, Kyle C Stamper, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosaSandra Mikhail, Nivedita B Singh, Razieh Kebriaei, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2020
Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insightsRazieh Kebriaei, Seth A Rice, Nivedita B Singh, et al.
Antibiotics (Basel, Switzerland)|October 17, 2020
Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic ModelJacinda C Abdul-Mutakabbir, Razieh Kebriaei, Kyle C Stamper, et al.
Materials (Basel, Switzerland)|July 25, 2018
Combination of Vancomycin and Cefazolin Lipid Nanoparticles for Overcoming Antibiotic Resistance of MRSAKetki Bhise, Samaresh Sau, Razieh Kebriaei, et al.
Antimicrobial Agents and Chemotherapy|August 16, 2021
Exebacase in Addition to Daptomycin against MRSARazieh Kebriaei, Kyle C Stamper, Katherine L Lev, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2020
Bacteriophage-Antibiotic Combination Strategy: an Alternative against Methicillin-Resistant Phenotypes of Staphylococcus aureusRazieh Kebriaei, Katherine Lev, Taylor Morrisette, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2021
<i>In Vitro</i> Antibacterial Activity of Cefiderocol against Multidrug-Resistant Acinetobacter baumanniiJacinda C Abdul-Mutakabbir, Logan Nguyen, Philip T Maassen, et al.
Pageof 2